Integrin receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 19, 544360, 544393, 546122, 546194, 5462734, 5462774, 546300, 546309, 546331, C07K 5023, A61K 3805, A61K 3806

Patent

active

059523069

ABSTRACT:
Fibrinogen receptor antagonists having the formula ##STR1## for example ##STR2## which are useful for inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.

REFERENCES:
patent: 3553227 (1971-01-01), Westland
patent: 4122255 (1978-10-01), Krapcho et al.
patent: 4250183 (1981-02-01), Krastinat
patent: 4684722 (1987-08-01), Sundeen
patent: 5227490 (1993-07-01), Hartman et al.
patent: 5264420 (1993-11-01), Duggan et al.
patent: 5281585 (1994-01-01), Duggan et al.
patent: 5292756 (1994-03-01), Duggan et al.
patent: 5294616 (1994-03-01), Duggan et al.
patent: 5321034 (1994-06-01), Duggan et al.
patent: 5358956 (1994-10-01), Hartman et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Integrin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Integrin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Integrin receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1509780

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.